Lignende værker: Novel Anticancer Strategies (Volume II)
- Applications of Nanomaterials in Biomedical Imaging and Cancer Therapy
- Cancer Nanomedicine
- Delivery of Molecules Using Nanoscale Systems for Cancer Treatment and/or Diagnosis
- Nanomaterials for Drug Delivery and Cancer Therapy
- Novel Anticancer Strategies
- Immunotherapy, Tumor Microenvironment and Survival Signaling
- Nanomaterials for Drug Delivery and Cancer Therapy
- EPR Effect-Based Tumor Targeted Nanomedicine
- Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers
- Exosomes in Cancers Therapy
- Recent Progress of Nanomedicine and Targeted Drug Delivery for Cancer Treatment
- Liposomes
- Targeted Cancer Therapy and Mechanisms of Resistance
- Targeting Wnt Signaling in Cancer: Opportunities Abound If We Can Avoid the Sword of Damocles
- Cavitation-Enhanced Drug Delivery and Immunotherapy
- Natural Nanoparticle for Cancer Diagnosis and Treatment
- Prospects from Diagnosis to Treatment in Cancer Using Magnetic Methods
- Protein Kinases
- Molecular Mechanisms of Tumor Progression and New Therapeutic Strategies for Urological Cancers, 2nd Edition
- Application of Nanomaterials in Biomedical Imaging and Cancer Therapy
- Magnetic Nanomaterials for Hyperthermia-Based Therapy, Imaging, and Drug Delivery
- Advanced Nanomaterials in Biomedical Application
- Therapeutic Landscapes in Colorectal Carcinoma
- Tumor Microenvironment and Resistance to Current Therapies
Emne: Breast cancer treatment
- Emne: Inorganic nanoparticles
- Emne: Active targeting
- Emne: cathepsins
- Emne: BAX
- Emne: MOMP
- Emne: ubiquitination
- Emne: apoptosis
- Emne: chemotherapy
- Emne: cancer
- Emne: nanoerythrosome
- Emne: nanoerythrocyte
- Emne: nanovesicles
- Emne: biomimetic
- Emne: cancer therapy
- Emne: diagnostics
- Emne: imaging agents
- Emne: cell cycle
- Emne: cyclin-dependent kinase
- Emne: p16
- Emne: p21
- Emne: p27
- Emne: breast cancer
- Emne: prognosis
- Emne: drug delivery
- Emne: HL60
- Emne: leukemia
- Emne: prodrug
- Emne: resistance
- Emne: retinoic acid
- Emne: vitamin K
- Emne: drug repurposing
- Emne: COVID-19
- Emne: pandemic
- Emne: vaccination
- Emne: multi-drug resistance
- Emne: enhanced permeation and retention effect
- Emne: nanotherapeutics
- Emne: cancer theranostic
- Emne: clinical translation
- Emne: cell-penetrating peptides
- Emne: protein transduction domains
- Emne: tumor imaging
- Emne: targeted therapies
- Emne: dog
- Emne: comparative oncology
- Emne: molecular targets
- Emne: spheroids
- Emne: tumoroids
- Emne: hydrogel
- Emne: collagen
- Emne: agarose
- Emne: mammary spheroids
- Emne: tissue engineering
- Emne: cisplatin
- Emne: melanoma
- Emne: melanin nanoparticles
- Emne: cytotoxicity
- Emne: laser medical applications
- Emne: hyperthermia
- Emne: antimitotics
- Emne: mitotic slippage
- Emne: spindle assembly checkpoint
- Emne: clinical trials
- Emne: TRAIL
- Emne: cancer stem cells
- Emne: TRAIL resistance
- Emne: angiogenesis
- Emne: on-demand drug delivery systems
- Emne: electrospun nanofibers
- Emne: poly (N-isopropylacrylamide)
- Emne: gold nanorods
- Emne: paclitaxel
- Emne: β-Cyclodextrin
- Emne: SPIONs
- Emne: metallodrugs
- Emne: RAPTA derivatives
- Emne: phosphino-amine ligands
- Emne: CTCs
- Emne: NSCLCs
- Emne: metastasis suppression
- Emne: curcumin
- Emne: flavonoids
- Emne: TNBC
- Emne: immunotherapy
- Emne: immune checkpoint
- Emne: nanocarrier
- Emne: combinational immunotherapy
- Emne: lung cancer
- Emne: miRNA
- Emne: oncomiRs
- Emne: photodynamic therapy PDT
- Emne: porphyrin
- Emne: iron oxide nanoparticles
- Emne: mesoporous silica nanoparticles
- Emne: antibody functionalization
- Emne: targeted drug delivery systems
- Emne: molecular-targeted therapies
- Emne: multifunctional enzymes
- Emne: HCC
- Emne: CHRNA5
- Emne: metastasis
- Emne: stemness property
- Emne: sorafenib sensitivity
- Emne: neoantigens
- Emne: vaccine
- Emne: Patched
- Emne: chemotherapy resistance
- Emne: metastases
- Emne: persistent cells
- Emne: adrenocortical carcinoma
- Emne: BUB3
- Emne: mitosis
- Emne: senescence
- Emne: anticancer target
- Emne: boron neutron capture therapy
- Emne: 4-borono-l-phenylalanine
- Emne: drug discovery
- Emne: solubility
- Emne: mebendazole
- Emne: polymer
- Emne: HPMA
- Emne: controlled drug release
- Emne: PLK1
- Emne: BI2536
- Emne: Navitoclax
- Emne: slippage
- Emne: PD-1
- Emne: gemcitabine
- Emne: new anti-cancer drugs
- Emne: precision medicine
- Emne: undruggable targets
- Emne: non-coding RNAs
- Emne: oligonucleotide therapeutics
- Emne: n/a
- Emne: thema EDItEUR::M Medicine and Nursing
- Emne: thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and dis...
Emne: Photodynamic therapy
- Emne: Inorganic nanoparticles
- Emne: Active targeting
- Emne: cathepsins
- Emne: BAX
- Emne: MOMP
- Emne: ubiquitination
- Emne: apoptosis
- Emne: chemotherapy
- Emne: cancer
- Emne: nanoerythrosome
- Emne: nanoerythrocyte
- Emne: nanovesicles
- Emne: biomimetic
- Emne: cancer therapy
- Emne: diagnostics
- Emne: imaging agents
- Emne: cell cycle
- Emne: cyclin-dependent kinase
- Emne: p16
- Emne: p21
- Emne: p27
- Emne: breast cancer
- Emne: prognosis
- Emne: drug delivery
- Emne: HL60
- Emne: leukemia
- Emne: prodrug
- Emne: resistance
- Emne: retinoic acid
- Emne: vitamin K
- Emne: drug repurposing
- Emne: COVID-19
- Emne: pandemic
- Emne: vaccination
- Emne: multi-drug resistance
- Emne: enhanced permeation and retention effect
- Emne: nanotherapeutics
- Emne: cancer theranostic
- Emne: clinical translation
- Emne: cell-penetrating peptides
- Emne: protein transduction domains
- Emne: tumor imaging
- Emne: targeted therapies
- Emne: dog
- Emne: comparative oncology
- Emne: molecular targets
- Emne: spheroids
- Emne: tumoroids
- Emne: hydrogel
- Emne: collagen
- Emne: agarose
- Emne: mammary spheroids
- Emne: tissue engineering
- Emne: cisplatin
- Emne: melanoma
- Emne: melanin nanoparticles
- Emne: cytotoxicity
- Emne: laser medical applications
- Emne: hyperthermia
- Emne: antimitotics
- Emne: mitotic slippage
- Emne: spindle assembly checkpoint
- Emne: clinical trials
- Emne: TRAIL
- Emne: cancer stem cells
- Emne: TRAIL resistance
- Emne: angiogenesis
- Emne: on-demand drug delivery systems
- Emne: electrospun nanofibers
- Emne: poly (N-isopropylacrylamide)
- Emne: gold nanorods
- Emne: paclitaxel
- Emne: β-Cyclodextrin
- Emne: SPIONs
- Emne: metallodrugs
- Emne: RAPTA derivatives
- Emne: phosphino-amine ligands
- Emne: CTCs
- Emne: NSCLCs
- Emne: metastasis suppression
- Emne: curcumin
- Emne: flavonoids
- Emne: TNBC
- Emne: immunotherapy
- Emne: immune checkpoint
- Emne: nanocarrier
- Emne: combinational immunotherapy
- Emne: lung cancer
- Emne: miRNA
- Emne: oncomiRs
- Emne: photodynamic therapy PDT
- Emne: porphyrin
- Emne: iron oxide nanoparticles
- Emne: mesoporous silica nanoparticles
- Emne: antibody functionalization
- Emne: targeted drug delivery systems
- Emne: molecular-targeted therapies
- Emne: multifunctional enzymes
- Emne: HCC
- Emne: CHRNA5
- Emne: metastasis
- Emne: stemness property
- Emne: sorafenib sensitivity
- Emne: neoantigens
- Emne: vaccine
- Emne: Patched
- Emne: chemotherapy resistance
- Emne: metastases
- Emne: persistent cells
- Emne: adrenocortical carcinoma
- Emne: BUB3
- Emne: mitosis
- Emne: senescence
- Emne: anticancer target
- Emne: boron neutron capture therapy
- Emne: 4-borono-l-phenylalanine
- Emne: drug discovery
- Emne: solubility
- Emne: mebendazole
- Emne: polymer
- Emne: HPMA
- Emne: controlled drug release
- Emne: PLK1
- Emne: BI2536
- Emne: Navitoclax
- Emne: slippage
- Emne: PD-1
- Emne: gemcitabine
- Emne: new anti-cancer drugs
- Emne: precision medicine
- Emne: undruggable targets
- Emne: non-coding RNAs
- Emne: oligonucleotide therapeutics
- Emne: n/a
- Emne: thema EDItEUR::M Medicine and Nursing
- Emne: thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and dis...